The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy

Yee Chung Cheng, Gabriela Rondón, Ying Yang, Terry L. Smith, James L. Gajewski, Michele L. Donato, Elizabeth J. Shpall, Roy Jones, Gabriel N. Hortobagyi, Richard E. Champlin, Naoto T. Ueno

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences